MISSION® pLKO.1-puro ARHGDIA shRNA Control Transduction Particles

Positive control targeting ARHGDIA

MISSION TurboGFP Control Transduction Particles
Pricing and availability is not currently available.

product line



capture ELISA: 106 ng/mL using p24

shipped in

dry ice

storage temp.


Looking for similar products? Visit Product Comparison Guide

General description

This control is intended for use as a positive control for knockdown of human gene targets when used with clones of the MISSION TRC human shRNA collections. The lentiviral format of this product permits direct transduction of target cells. These particles are produced from a 3rd generation transfer vector (pLKO.1) and are self-inactivating and replication incompetent for safety purposes.

The MISSION Rho GDP Dissociation Inhibitor (GDI) alpha (ARHGDIA) shRNA Control Transduction Particles contains a short hairpin sequence targeting the human Rho GDP Dissociation Inhibitor (GDI) alpha transcript (Gene Symbol: ARHGDIA). Rho GDP dissociation inhibitor (GDI) alpha (ARHGDIA) is a ubiquitously expressed protein that acts on human Rho GTPases including RhoA, Rac1 and Cdc42, by keeping these proteins locked in an inactive state. Complete understanding of ARHGDIA′s roles is still being elucidated but it is believed to be involved in various signal transduction pathways and cellular cytoskeleton functions. The MISSION Rho GDP Dissociation Inhibitor (GDI) alpha (ARHGDIA) shRNA Control Transduction Particles are produced from the sequence-verified lentiviral-based pLKO.1 plasmid clone (Product No. SHC009, Clone No. TRNC0000008004) chosen from the available complete target set (NM_004309) and has produced consistent knockdown of 90% compared to normal gene expression in the human epithelial lung carcinoma cell line A549 via quantitative RT PCR analysis and Western blot analysis (Antibody Product No. R3025).

MISSION Rho GDP Dissociation Inhibitor (GDI) alpha (ARHGDIA) shRNA Control Transduction Particles, as all other MISSION lentiviral format clones, are pseudotyped with an envelope G glycoprotein from Vesicular Stomatitis Virus (VSV-G), allowing transduction of a wide variety of mammalian cells. The lentiviral particles are provided as a frozen stock in a volume of 200 μl with a minimum titer of 1 x 106 TU/ml (via p24 titering assay). Upon transduction, the sequence integrates into the host cell genome and transduced cells can be selected using puromycin resistance.
When conducting experiments using MISSION® shRNA clones, the proper controls should be a key element of your experimental design to allow for accurate interpretation of knockdown results. The MISSION Control Transduction Particles are a critical positive control to monitor transduction efficiency.
To see more application data, protocols, vector maps visit


To see more application data, protocols, vector maps visit

Legal Information

MISSION is a registered trademark of Sigma-Aldrich Co. LLC


UN3373 - class 6.2 Biological substance, Category B

WGK Germany


Ruth S Cruz Cosme et al.
Journal of virology, 83(7), 2839-2850 (2009-01-16)
Human cytomegalovirus (HCMV), a member of the beta subgroup of the family Herpesviridae, causes serious health problems worldwide. HCMV gene expression in host cells is a well-defined sequential process: immediate-early (IE) gene expression, early-gene expression, DNA replication, and late-gene expression....

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon


Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.